Stay updated on Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Sign up to get notified when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.

Latest updates to the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page
- Check4 days agoChange DetectedAdded a Locations section with Basel-Landschaft as a participating site and updated the record to revision 3.3.3; the prior Basel-Landschaft Locations entry was removed.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedPublications note updated to state that publications are automatically filled from PubMed and may not all relate to the study, replacing the prior PubMed-based wording; the revision tag was updated from v3.2.0 to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoval of a general government funding status notice from the page. The study details, eligibility criteria, and results sections remain unchanged.SummaryDifference0.4%

- Check54 days agoChange DetectedScreenshots show only minor UI/layout adjustments with no changes to the core study content (eligibility criteria, outcomes, or treatment arms). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference3%

- Check90 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.SummaryDifference0.4%

Stay in the know with updates to Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.